Spasmin-Lösung 50% ad us. vet.

Hauptinformation

  • Handelsname:
  • Spasmin-Lösung 50% ad us. vet., Injektionslösung
  • Darreichungsform:
  • Injektionslösung
  • Verwenden für:
  • Tiere
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Spasmin-Lösung 50% ad us. vet., Injektionslösung
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Analgeticum für Rinder, Schafe, Ziegen, Pferde, Schweine, Hunde und Katzen

Weitere Informationen

Status

  • Quelle:
  • Institut für Veterinärpharmakologie
  • Zulassungsnummer:
  • 14245
  • Letzte Änderung:
  • 02-09-2017

Packungsbeilage

Spasmin-Lösung 50% ad us. vet., Injektionslösung

Werner Stricker AG

Analgeticum für Rinder, Schafe, Ziegen, Pferde, Schweine, Hunde und Katzen

ATCvet: QN02BB02

Zusammensetzung

Metamizolum natricum 500 mg

Antiox.: Natrii thiosulfas1 mg

Aqua ad injectabilia ad 1 ml

Fachinformationen Wirkstoffe (CliniPharm)

Metamizol

Eigenschaften / Wirkungen

Das Natrium novaminsulfonicum eignet sich besonders für die parenterale

Schmerzlinderung. Die quergestreifte und die glatte Muskulatur, welche infolge von

Schmerzzuständen verkrampft ist, entspannt sich, ohne dass physiologische

Kontraktionen beeinflusst werden.

Indikationen

Analgeticum, Antirheumaticum und Antipyreticum. Besonders zur Schmerzbekämpfung

bei Verletzungen, als Spasmolyticum bei Schlundkrampf infolge Fremdkörperstenose bei

Pferd, Rind und Schwein, Krampfkolik und spastischer Obstipation, bei Lumbago und

Gelenkentzündung.

Pferd, Rind 20 - 50 mg Metamizol pro kg KGW (20 - 50 ml i.v.)

Fohlen

20 - 50 mg Metamizol pro kg KGW (5 - 15 ml i.v.)

Schwein

15 - 50 mg Metamizol i.m. pro kg KGW (10 - 30 ml i.v. oder

i.m.)

Schaf, Ziege20 - 40 mg Metamizol i.m. pro kg KGW (0.5 - 6 ml i.v. oder

i.m.)

Hund

500 mg - 2,5 g pro Tier (1 - 5 ml i.v. oder i.m.)

Katze

250 - 500 mg pro Tier (0.5 - 1 ml i.v. oder i.m.)

Wiederholungen nach 24 Stunden möglich.

Anwendungseinschränkungen

Kontraindikationen

Metamizol soll nicht angewandt weden bei Tieren mit Störungen im hämatopoëtischen

System.

Unerwünschte Wirkungen

VetVigilance: Pharmacovigilance-Meldung erstatten

essbares Gewebe

12 Tage (Pferd, Rind, Schaf, Ziege); Schwein 15 Tage

Milch:

4 Tage (Rind, Schaf, Ziege); nicht bei Pferden anwenden, deren Milch

für den Konsum vorgesehen ist.

Sonstige Hinweise

Vor Kinderhänden geschützt aufbewahren!

Aufbrauchsfrist nach Entnahme der ersten Dosis: 1 Woche.

Aufbewahren bei Raumtemperatur (15 - 25°C).

Packungen

Flasche zu 100 ml

Abgabekategorie: B

Swissmedic Nr. 14'245

Informationsstand: 03/2008

Dieser Text ist behördlich genehmigt.

15-11-2018

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Safety and efficacy of Monimax® (monensin sodium and nicarbazin) for chickens for fattening and chickens reared for laying

Published on: Wed, 14 Nov 2018 The coccidiostat Monimax® (monensin sodium and nicarbazin) is considered safe for chickens for fattening and chickens reared for laying at the highest use level of 50 mg monensin and 50 mg nicarbazin/kg complete feed. This conclusion is extended to chickens reared for laying. For both active substances, the metabolic pathways in the chicken are similar to those in the turkey and rat. Nicarbazin, when ingested, is rapidly split in its two components dinitrocarbanilide (DNC)...

Europe - EFSA - European Food Safety Authority Publications

15-11-2018

Feliserin PRC ad us. vet.

Feliserin PRC ad us. vet.

● Änderung Text gesamte Arzneimittelinformation

Institut für Veterinärpharmakologie und toxikologie

13-11-2018

Felimazole 2.5 mg ad us. vet., Filmtabletten fuer Katzen

Felimazole 2.5 mg ad us. vet., Filmtabletten fuer Katzen

● Änderung Text "Anwendungseinschränkungen", "Wechselwirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

13-11-2018

Felimazole 5 mg ad us. vet., Filmtabletten fuer Katzen

Felimazole 5 mg ad us. vet., Filmtabletten fuer Katzen

● Änderung Text "Anwendungseinschränkungen", "Wechselwirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

13-11-2018

Pyrogenium compositum ad us. vet., fluessige Verduennung

Pyrogenium compositum ad us. vet., fluessige Verduennung

● Änderung Präparatenamen sowie Text "Zusammensetzung", "Indikationen", "Anwendungseinschränkungen", "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

10-11-2018

Pest categorisation of Popillia japonica

Pest categorisation of Popillia japonica

Published on: Thu, 08 Nov 2018 00:00:00 +0100 The Panel on Plant Health performed a pest categorisation of Popillia japonica(Coleoptera: Scarabaeidae) for the EU. P. japonica is a distinguishable species listed in Annex IAII of Council Directive 2000/29/EC. It is native to Japan but established in the USA in the early 20th century. It spreads from New Jersey to most US states east of the Mississippi, some to the west and north into Canada. P. japonica feeds on over 700 plant species. Adults attack folia...

Europe - EFSA - European Food Safety Authority Publications

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

8-11-2018

Marbonor 10% ad us. vet., Injektionsloesung

Marbonor 10% ad us. vet., Injektionsloesung

● Die Neuzulassung erfolgte am 08.11.2018.

Institut für Veterinärpharmakologie und toxikologie

6-11-2018

Levamisol 100 mg/ml ad us. vet., Injektionsloesung

Levamisol 100 mg/ml ad us. vet., Injektionsloesung

● Die Neuzulassung erfolgte am 06.11.2018.

Institut für Veterinärpharmakologie und toxikologie

6-11-2018

Suanovil 20 ad us. vet., Injektionsloesung

Suanovil 20 ad us. vet., Injektionsloesung

● Umwandlung in Exportzulassung (Exportspezialität): nur für den Vertrieb im Ausland

Institut für Veterinärpharmakologie und toxikologie

5-11-2018

Effipro Spot On Hunde S ad us. vet., Loesung zum Auftropfen

Effipro Spot On Hunde S ad us. vet., Loesung zum Auftropfen

● Änderung Text "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

5-11-2018

Effipro Spot On Hunde M ad us. vet., Loesung zum Auftropfen

Effipro Spot On Hunde M ad us. vet., Loesung zum Auftropfen

● Änderung Text "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

5-11-2018

Effipro Spot On Hunde L ad us. vet., Loesung zum Auftropfen

Effipro Spot On Hunde L ad us. vet., Loesung zum Auftropfen

● Änderung Text "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

5-11-2018

Effipro Spot On Hunde XL ad us. vet., Loesung zum Auftropfen

Effipro Spot On Hunde XL ad us. vet., Loesung zum Auftropfen

● Änderung Text "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

5-11-2018

Effipro Spot On Katzen ad us. vet., Loesung zum Auftropfen

Effipro Spot On Katzen ad us. vet., Loesung zum Auftropfen

● Änderung Text "Sonstige Hinweise" und "Packungen"

Institut für Veterinärpharmakologie und toxikologie

1-11-2018

Three research projects to increase our knowledge of medicinal cannabis

Three research projects to increase our knowledge of medicinal cannabis

Three projects have just been granted funds to give us more knowledge about the efficacy of medicinal cannabis. A total of DKK 5 million have been distributed of the funds that were appropriated by the negotiating parliamentary parties under the special funds agreement 2018-2021 to accumulate scientific knowledge of medicinal cannabis.

Danish Medicines Agency

1-11-2018

Seresto ad us. vet., Halsband fuer Hunde groesser 8 kg

Seresto ad us. vet., Halsband fuer Hunde groesser 8 kg

● Änderung Text "Eigenschaften/Wirkung", "Indikationen", "Dosierung/Anwendung", "Anwendungseinschränkungen", "Unerwünschte Wirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

1-11-2018

Seresto ad us. vet., Halsband fuer Katzen und Hunde kleinergleich 8 kg

Seresto ad us. vet., Halsband fuer Katzen und Hunde kleinergleich 8 kg

● Änderung Text "Eigenschaften/Wirkung", "Indikationen", "Dosierung/Anwendung", "Anwendungseinschränkungen", "Unerwünschte Wirkungen" und "Sonstige Hinweise"

Institut für Veterinärpharmakologie und toxikologie

31-10-2018

Safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos when used as a feed flavouring for all animal species

Safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos when used as a feed flavouring for all animal species

Published on: Tue, 30 Oct 2018 00:00:00 +0100 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of a super critical carbon dioxide extract of Humulus lupulus L. flos (hop strobiles) when used as a sensory feed additive for all animal species. The additive is specified to containing 40% beta acids and less than 0.2% alpha acids. Known substances of conce...

Europe - EFSA - European Food Safety Authority Publications

16-11-2018

Advantan 0,1 % Lösung

Rote - Liste

15-11-2018

Ciclopirox acis® 1% Lösung

Rote - Liste

15-11-2018

CRYSVITA 10/20/30 mg Injektionslösung

Rote - Liste

14-11-2018

The @US_FDA issues a safety communication cautioning doctors & patients of the risks associated w/ using medications that are not approved for use w/ implanted pumps that are delivered into the spinal fluid to treat or   manage pain:  https://go.usa.gov/x

The @US_FDA issues a safety communication cautioning doctors & patients of the risks associated w/ using medications that are not approved for use w/ implanted pumps that are delivered into the spinal fluid to treat or manage pain: https://go.usa.gov/x

The @US_FDA issues a safety communication cautioning doctors & patients of the risks associated w/ using medications that are not approved for use w/ implanted pumps that are delivered into the spinal fluid to treat or manage pain: https://go.usa.gov/xPfuw  #FDA #MedicalDevice pic.twitter.com/kgDSx2PQzn

FDA - U.S. Food and Drug Administration

13-11-2018

#DYK November is #DiabetesAwarenessMonth. As the number of people diagnosed with diabetes continues to grow, @US_FDA  encourages patients and caregivers to beware of illegally markets  diabetes treatments. Check out our Consumer Update on this issue  http

#DYK November is #DiabetesAwarenessMonth. As the number of people diagnosed with diabetes continues to grow, @US_FDA encourages patients and caregivers to beware of illegally markets diabetes treatments. Check out our Consumer Update on this issue http

#DYK November is #DiabetesAwarenessMonth. As the number of people diagnosed with diabetes continues to grow, @US_FDA encourages patients and caregivers to beware of illegally markets diabetes treatments. Check out our Consumer Update on this issue https://go.usa.gov/xPfDx  pic.twitter.com/OGwOusdP1w

FDA - U.S. Food and Drug Administration

12-11-2018

Venofundin® 60 mg/ml Infusionslösung

Rote - Liste

12-11-2018

Tetraspan® 6 % Infusionslösung

Rote - Liste

12-11-2018

Tetraspan® 10 % Infusionslösung

Rote - Liste

8-11-2018

There's only 1 week until the 2018 Patient Engagement Advisory Committee meeting. Join the @US_FDA on Nov 15 to discuss patient-generated health data from sources like social media, activity trackers, and patient-driven registries.pic.twitter.com/WkDNnXqm

There's only 1 week until the 2018 Patient Engagement Advisory Committee meeting. Join the @US_FDA on Nov 15 to discuss patient-generated health data from sources like social media, activity trackers, and patient-driven registries.pic.twitter.com/WkDNnXqm

There's only 1 week until the 2018 Patient Engagement Advisory Committee meeting. Join the @US_FDA on Nov 15 to discuss patient-generated health data from sources like social media, activity trackers, and patient-driven registries. pic.twitter.com/WkDNnXqmbw

FDA - U.S. Food and Drug Administration

8-11-2018

Voluven 10 % Infusionslösung

Rote - Liste

6-11-2018

November is #DiabetesAwarenessMonth  #DYK using a glucose meter to check and monitor blood sugar is a daily part of life for millions of Americans with diabetes? Check out the @US_FDA's tips on how to safely use glucose meters and test strips for diabetes

November is #DiabetesAwarenessMonth #DYK using a glucose meter to check and monitor blood sugar is a daily part of life for millions of Americans with diabetes? Check out the @US_FDA's tips on how to safely use glucose meters and test strips for diabetes

November is #DiabetesAwarenessMonth #DYK using a glucose meter to check and monitor blood sugar is a daily part of life for millions of Americans with diabetes? Check out the @US_FDA's tips on how to safely use glucose meters and test strips for diabetes: https://go.usa.gov/xPdK4 

FDA - U.S. Food and Drug Administration

6-11-2018

Hospasol 145 mmol/l Infusionslösung

Rote - Liste

6-11-2018

Regiocit Hämofiltrationslösung

Rote - Liste

2-11-2018

.@US_FDA  issues a class I recall: Roche Diagnostics recalls CoaguChek  XS PT Test  Strips due to inaccurate INR test results. Find out more:  https://go.usa.gov/xPVER  #FDA #MedicalDevicepic.twitter.com/EYmVZHrUZc

.@US_FDA issues a class I recall: Roche Diagnostics recalls CoaguChek XS PT Test Strips due to inaccurate INR test results. Find out more: https://go.usa.gov/xPVER  #FDA #MedicalDevicepic.twitter.com/EYmVZHrUZc

. @US_FDA issues a class I recall: Roche Diagnostics recalls CoaguChek XS PT Test Strips due to inaccurate INR test results. Find out more: https://go.usa.gov/xPVER  #FDA #MedicalDevice pic.twitter.com/EYmVZHrUZc

FDA - U.S. Food and Drug Administration

2-11-2018

Check out @US_FDA's information on Direct-to-Consumer Tests:  https://go.usa.gov/xPVPu  #MedicalDevice #FDA

Check out @US_FDA's information on Direct-to-Consumer Tests: https://go.usa.gov/xPVPu  #MedicalDevice #FDA

Check out @US_FDA's information on Direct-to-Consumer Tests: https://go.usa.gov/xPVPu  #MedicalDevice #FDA

FDA - U.S. Food and Drug Administration

2-11-2018

#DYK the @US_FDA recently authorized the first direct-to-consumer test   for detecting genetic variants that may be associated with medication   metabolism? Learn more about the authorization:  https://go.usa.gov/xPVUt  #MedicalDevice #FDA

#DYK the @US_FDA recently authorized the first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism? Learn more about the authorization: https://go.usa.gov/xPVUt  #MedicalDevice #FDA

#DYK the @US_FDA recently authorized the first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism? Learn more about the authorization: https://go.usa.gov/xPVUt  #MedicalDevice #FDA

FDA - U.S. Food and Drug Administration

2-11-2018

Tramundin® 50 mg Filmtabletten

Rote - Liste

1-11-2018

The @US_FDA issues a letter to health care providers regarding possible battery failure in Getinge's Maquet/Datascope intra-aortic balloon pumps. Read the letter here:  https://go.usa.gov/xPyHT  #MedicalDevice

The @US_FDA issues a letter to health care providers regarding possible battery failure in Getinge's Maquet/Datascope intra-aortic balloon pumps. Read the letter here: https://go.usa.gov/xPyHT  #MedicalDevice

The @US_FDA issues a letter to health care providers regarding possible battery failure in Getinge's Maquet/Datascope intra-aortic balloon pumps. Read the letter here: https://go.usa.gov/xPyHT  #MedicalDevice

FDA - U.S. Food and Drug Administration

1-11-2018

The @US_FDA warns patients & health care providers should not change drug treatment based on results from certain genetic tests w/ unapproved claims to predict a patient’s response to specific medications. Read the Safety Communication here:  https://go.u

The @US_FDA warns patients & health care providers should not change drug treatment based on results from certain genetic tests w/ unapproved claims to predict a patient’s response to specific medications. Read the Safety Communication here: https://go.u

The @US_FDA warns patients & health care providers should not change drug treatment based on results from certain genetic tests w/ unapproved claims to predict a patient’s response to specific medications. Read the Safety Communication here: https://go.usa.gov/xPysF  #MedicalDevice

FDA - U.S. Food and Drug Administration